Trends of T. cruzi infection based on data from blood bank screening.
Between October 1988 and April 1989 a cross-sectional survey was carried out in six out of eight blood banks of Goiánia, Central Brazil. Subjects attending for first-time blood donation in the mornings of the study period (n = 1358) were interviewed and screened for T. cruzi infection as a part of a major study among blood donors. Tests to anti-T. cruzi antibodies were performed, simultaneously, by indirect hemagglutination test (IHA) and complement fixation test (CFT). A subject was considered seropositive when any one of the two tests showed a positive result. Information on age, sex, place of birth, migration and socio-economic level was recorded. Results from this survey were compared with seroprevalence rates obtained in previous studies in an attempt to analyse trend of T. cruzi infection in an endemic urban area. The overall seroprevalence of T. cruzi infection among first-time donors was found to be 3.5% (95% confidence interval 2.5%-4.5%). The seroprevalence rate increased with age up to 45 years and then decreased. Migrants from rural areas had higher seroprevalence rates than subjects from urban counties (1.8%-16.2% vs. 0%-3.6%). A four fold decrease in prevalence rates was observed when these rates were compared with those of fifteen years ago. Two possible hypotheses to explain this difference were suggested: 1. a cohort effect related with the decrease of transmission in rural areas and/or 2. a differential proportion of people of rural origin among blood donors between the two periods. The potential usefulness of blood banks as a source of epidemiological information to monitor trends of T. cruzi infection in an urban adult population was stressed.
Zicker
F
F
Departamento de Saúde Coletiva, Instituto de Patologia Tropical e Saúde Pública/UFG, Goiânia, GO, Brazil.
Martelli
C M
CM
de Andrade
A L
AL
Almeida e Silva
S
S
D000328:Adult; D000818:Animals; D000913:Antibodies, Protozoan / Q000032:analysis; D001782:Blood Donors; D001938:Brazil / Q000453:epidemiology; D014355:Chagas Disease / Q000453:epidemiology*; D003430:Cross-Sectional Studies; D006801:Humans; D008875:Middle Aged; D014349:Trypanosoma cruzi / Q000276:immunology
D000913:Antibodies, Protozoan